SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ENDOCYTE INC
(NQNM:ECYT Last Sale: 15.37 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ECYT : $15.37)
$551 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
WEST LAFAYETTE, IN 47906 Research Report Earnings Snapshot - Last 11/05/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports

P. Ron Ellis, Pres./CEO, Michael A. Sherman, CFO
Biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. IPO at $6 February 3, 2011. Raised $75 million, selling 12.5 million shares, 45% of the outstanding. Lead Manager: RBC Capital Markets.
Historical Charts    Technical Analysis
No Historical Data available for ECYT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ECYT $15.37 $ 0 $14.69 $15.66 239,031 $7.5 $19 35,870
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $551,322

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex